Cargando…
IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators
Plasminogen activator inhibitor (PAI)-1 is the principal inhibitor of plasminogen activators, and is responsible for the degradation of fibrin and extracellular matrix. IMD-4690 is a newly synthesized inhibitor for PAI-1, whereas the effect on allergic airway inflammation and remodeling is still unc...
Autores principales: | Tezuka, Toshifumi, Ogawa, Hirohisa, Azuma, Masahiko, Goto, Hisatsugu, Uehara, Hisanori, Aono, Yoshinori, Hanibuchi, Masaki, Yamaguchi, Yoichi, Fujikawa, Tomoyuki, Itai, Akiko, Nishioka, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364779/ https://www.ncbi.nlm.nih.gov/pubmed/25785861 http://dx.doi.org/10.1371/journal.pone.0121615 |
Ejemplares similares
-
Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017) -
Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice
por: Kishi, Masami, et al.
Publicado: (2018) -
An Autopsy Case of Aortic Intimal Sarcoma Initially Diagnosed as Polyarteritis Nodosa
por: Toyoda, Yuko, et al.
Publicado: (2016) -
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
por: Sato, Seidai, et al.
Publicado: (2017) -
The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma
por: Tada, Yukiyo, et al.
Publicado: (2014)